{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Crumlin Colorado Antrim",
      "state": "",
      "country": "United Kingdom",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "86039",
      "recalling_firm": "RANDOX LABORATORIES, LTD.",
      "address_1": "34 Diamond Rd",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Worldwide distribution - US Nationwide distribution including in the states of Puerto Rico and WV.",
      "recall_number": "Z-2753-2020",
      "product_description": "Randox Lipase Assay: Lipase Colorimetric R2 Substrate - Product Usage: A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma.",
      "product_quantity": "",
      "reason_for_recall": "Randox have confirmed imprecision of quality control and patient samples when using specific Randox Lipase R2 Substrate batches.",
      "recall_initiation_date": "20200626",
      "center_classification_date": "20200804",
      "termination_date": "20201019",
      "report_date": "20200812",
      "code_info": "Catalogue Numbers: LI015/000/UL, LI015/003/UL, LI015/000/UL  Lot #: 1049LI, 1051LI",
      "more_code_info": ""
    }
  ]
}